Related Experiment Video

Updated: Jul 4, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
08:02

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice

Published on: October 19, 2013

Pulmonary hypertension in an infant with achondroplasia

Ofer Schiller1, Michael Schwartz, Elchanan Bruckheimer

  • 1Department of Pediatrics B, Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.

Pediatric Neurosurgery
|June 17, 2008
PubMed

Insights

Pulmonary hypertension in achondroplasia may stem from multiple factors, including brainstem compression. Treating this compression improved respiratory and cardiac symptoms in a young child.

Area of Science:

  • Pediatric Cardiology
  • Neurology
  • Genetics

Background:

  • Achondroplasia is a common form of dwarfism characterized by disproportionate short stature.
  • Pulmonary hypertension is a serious complication that can occur in children with achondroplastic dwarfism.
  • The exact causes of pulmonary hypertension in achondroplasia are not fully understood.

Observation:

  • An 18-month-old child with achondroplasia presented with severe pulmonary hypertension and respiratory distress.
  • Initial treatment for an atrial septal defect (ASD) provided only partial clinical improvement.
  • Sleep monitoring revealed sleep apnea, oxygen desaturation, and carbon dioxide retention.

Findings:

  • Magnetic resonance imaging (MRI) identified medullary compression due to a stenotic foramen magnum.
  • Surgical craniocervical decompression significantly improved sleep disturbances.
  • Following decompression, pulmonary hypertension also showed marked improvement.

Implications:

  • Medullary compression should be considered as a potential contributing factor to pulmonary hypertension in achondroplasia.
  • Comprehensive evaluation, including neurological assessment, is crucial for managing complex cases of achondroplasia.
  • Craniocervical decompression may be an effective treatment for respiratory and cardiovascular complications in these patients.

More Related Videos

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: